1 / 21

Extracorporeal Membrane Oxygenation Following Lung Transplantation in Adult

Extracorporeal Membrane Oxygenation Following Lung Transplantation in Adult. ISKANDER AL-GITHMI, M.D., FRCSC, FRCSC (Ts & CDs), FCCP . Assistant Professor of Surgery Division of Cardiothoracic Surgery King Abdulaziz University.

nevina
Download Presentation

Extracorporeal Membrane Oxygenation Following Lung Transplantation in Adult

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Extracorporeal Membrane Oxygenation Following Lung Transplantation in Adult ISKANDER AL-GITHMI, M.D., FRCSC, FRCSC (Ts & CDs), FCCP. Assistant Professor of Surgery Division of Cardiothoracic Surgery King Abdulaziz University

  2. Extracorporeal Membrane Oxygenation Following Lung Transplantation • Lung transplantation is well established procedure. • Is the only acceptable option in selected patients with end-stage pulmonary disease refractory to max. medical treatment.

  3. According to ISHLT and international registry 23,716 lung transplantation were performed worldwide as of 2006. • Overall mortality following lung transplant is still notable, with one year survival is 80%.

  4. How many transplant recipients require ECMO? • Primary graft failure • Bridge for re-do lung transplant.

  5. Answer • Handful- Very small series spread over the last 3 decades. • 1975-1st case of ECMO used as a bridge to lung transplant was performed • 1991 Hannover group published the first report of long-term survival after using ECMO as bridge to re-do lung transplant

  6. 1992- Hannover group reported the first long term (12 months) survivor after using ECMO as bridge to primary lung transplant.

  7. Indications • Severe Allograft Failure • Bridge to bridge • Bridge to transplantation

  8. Primary Allograft Failure Criteria/ ISHLT: • Diffuse alveolar opacities exclusively involving allograft, developing within 72 hours after lung transplantation • PaO2 / FIO2 ratio < 200 beyond 48 hours post transplant • No other cause of graft failure identified such as rejection, infection or pulmonary venous obstruction

  9. Primary Graft Failure • 10-30% of transplant recipients develop primary graft failure • ECMO may provide lifesaving temporary support • ECMO long-term efficacy is controversial

  10. ECMO goals: • Maintain adequate oxygenation and ventilation • Decrease pulmonary artery pressure, to decrease trans-capillary gradients in pulmonary vasculature • Reduce rate and tidal volume of mechanical ventilation, to limit ventilator-induce lung injury

  11. Selective Use of ECMO After Lung Transplant • Meyers et al –Washington University conducted a retrospective study on: • 444 adult lung transplant -(1988-1998) • 12 patients (2.7%) require ECMO support for severe graft failure

  12. Conclusion: This data do not offer adequate information to assess ECMO risk factors.

  13. Clinical Risks Factors Associated with Graft Failure After Lung Transplant • Christie et al conducted cohort study on 255 consecutive lung transplants between 1991-2000 • Overall incidence of graft failure after transplant was 11.8% • Multivariate analysis shows the risk factors associated with the development of graft failure were: primary pulmonary HTN, female gender, donor age < 21 yrs > 45 yrs

  14. Long-term Survival of Transplant recipients After ECMO use for PGF • Bermudez et al conducted a study on: • 763 lung or heart-lung transplant • 58 patients (7.6%) required early [0-7 days after transplant] ECMO support for PGF • Mean duration of support was 5.5 days • Mean follow-up was 4.5 years

  15. Results

  16. Results • 30 days survival was 80% • 1 year survival was 39% • 5 years survival was 33% Conclusion: ECMO group survival is inferior to non ECMO group

  17. Conclusions: • Extracorporealmembrane oxygenation can provide acceptable support for PGF after lung transplantation. • Overall benefits of ECMO in lung transplantation for PGF is still being defined. • No registry exist that specifically collect ECMO data in the field of lung transplantation.

  18. Thank You

More Related